表紙
市場調査レポート

白血病向け試薬:パイプライン分析

Leukemia - Pipeline Review, 2015

発行 GlobalData 商品コード 342290
出版日 ページ情報 英文 93 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
白血病向け試薬:パイプライン分析 Leukemia - Pipeline Review, 2015
出版日: 2015年10月01日 ページ情報: 英文 93 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の、白血病診断用の試薬 (および関連製品) のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・分野別・地域別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発の動き・業界動向などを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 白血病向け試薬の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)

第4章 白血病診断用試薬:開発中のパイプライン製品 (企業別)

  • 白血病向け試薬の開発企業:パイプライン製品 (開発段階別)
  • 白血病向け試薬:開発段階別のパイプライン製品の一覧

第5章 白血病向け試薬の開発企業・製品の概要

  • Abbott Diagnostics
    • パイプライン製品および現在進行中の治験の概要
  • Acobiom
  • Adaptive Biotechnologies Corporation
  • BioSense Technologies, Inc.
  • Cancer Genetics, Inc.
  • Cepheid
  • Di.V.A.L Toscana srl
  • Diagnovus, LLC
  • DiaSorin S.p.A
  • Eutropics Pharmaceuticals, Inc.
  • Gendiag
  • Health Discovery Corporation
  • InVivoScribe Technologies, Inc.
  • IV Diagnostics, Inc.
  • Jaden BioScience Inc.
  • MolecularMD, Corp.
  • Monoquant Pty. Ltd.
  • Nodality, Inc.
  • NuCana BioMed Limited
  • Nuclea Biotechnologies Inc.
  • OncoVista Innovative Therapies, Inc.
  • Qiagen N.V.
  • Siemens Healthcare Diagnostics Inc.
  • Skyline Diagnostics BV
  • St. Jude Children's Research Hospital, Inc.
  • The Feinstein Institute for Medical Research
  • University of Barcelona
  • University of California, San Diego
  • University of Missouri
  • Vela Diagnostics
  • Vivia Biotech, S.L.
  • Wake Forest Baptist Medical Center
  • Xiamen Zeesan Biotech Co.,Ltd

第6章 白血病向け試薬:昨今の市場動向

第7章 付録

図表一覧

目次
Product Code: GDME0073EPD

GlobalData's Medical Devices sector report, "Leukemia - Pipeline Review, 2015" provides an overview of Leukemia diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Leukemia diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Leukemia diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Leukemia diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Leukemia diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Leukemia Overview

3. Products under Development

  • 3.1. Leukemia - Pipeline Products by Stage of Development
  • 3.2. Leukemia - Pipeline Products by Territory
  • 3.3. Leukemia - Pipeline Products by Regulatory Path
  • 3.4. Leukemia - Pipeline Products by Estimated Approval Date

4. Leukemia - Pipeline Products under Development by Companies

  • 4.1. Leukemia Companies - Pipeline Products by Stage of Development
  • 4.2. Leukemia - Pipeline Products by Stage of Development

5. Leukemia Companies and Product Overview

  • 5.1. Abbott Diagnostics Company Overview
    • 5.1.1. Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Acobiom Company Overview
    • 5.2.1. Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Adaptive Biotechnologies Corporation Company Overview
    • 5.3.1. Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. BioSense Technologies, Inc. Company Overview
    • 5.4.1. BioSense Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Cancer Genetics, Inc. Company Overview
    • 5.5.1. Cancer Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Cepheid Company Overview
    • 5.6.1. Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Di.V.A.L Toscana srl Company Overview
    • 5.7.1. Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Diagnovus, LLC Company Overview
    • 5.8.1. Diagnovus, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. DiaSorin S.p.A Company Overview
    • 5.9.1. DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Eutropics Pharmaceuticals, Inc. Company Overview
    • 5.10.1. Eutropics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Gendiag Company Overview
    • 5.11.1. Gendiag Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Health Discovery Corporation Company Overview
    • 5.12.1. Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. InVivoScribe Technologies, Inc. Company Overview
    • 5.13.1. InVivoScribe Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. IV Diagnostics, Inc. Company Overview
    • 5.14.1. IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Jaden BioScience Inc. Company Overview
    • 5.15.1. Jaden BioScience Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. MolecularMD, Corp. Company Overview
    • 5.16.1. MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Monoquant Pty. Ltd. Company Overview
    • 5.17.1. Monoquant Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Nodality, Inc. Company Overview
    • 5.18.1. Nodality, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. NuCana BioMed Limited Company Overview
    • 5.19.1. NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Nuclea Biotechnologies Inc. Company Overview
    • 5.20.1. Nuclea Biotechnologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. OncoVista Innovative Therapies, Inc. Company Overview
    • 5.21.1. OncoVista Innovative Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Qiagen N.V. Company Overview
    • 5.22.1. Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Siemens Healthcare Diagnostics Inc. Company Overview
    • 5.23.1. Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Skyline Diagnostics BV Company Overview
    • 5.24.1. Skyline Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. St. Jude Children's Research Hospital, Inc. Company Overview
    • 5.25.1. St. Jude Children's Research Hospital, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. The Feinstein Institute for Medical Research Company Overview
    • 5.26.1. The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. University of Barcelona Company Overview
    • 5.27.1. University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. University of California, San Diego Company Overview
    • 5.28.1. University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. University of Missouri Company Overview
    • 5.29.1. University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Vela Diagnostics Company Overview
    • 5.30.1. Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Vivia Biotech, S.L. Company Overview
    • 5.31.1. Vivia Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Wake Forest Baptist Medical Center Company Overview
    • 5.32.1. Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Xiamen Zeesan Biotech Co.,Ltd Company Overview
    • 5.33.1. Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview

6. Leukemia- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Leukemia - Pipeline Products by Stage of Development
  • Table 2: Leukemia - Pipeline Products by Territory
  • Table 3: Leukemia - Pipeline Products by Regulatory Path
  • Table 4: Leukemia - Pipeline Products by Estimated Approval Date
  • Table 5: Leukemia Companies - Pipeline Products by Stage of Development
  • Table 6: Leukemia - Pipeline Products by Stage of Development
  • Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
  • Table 9: CRLF2 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
  • Table 10: D13S319/CEP12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
  • Table 11: D13S319/CEP12 Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
  • Table 12: IKZF1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Status
  • Table 13: IKZF1 Companion Diagnostic Assay - Acute Lymphocytic Leukemia - Product Description
  • Table 14: MCL1 Companion Diagnostic Assay - Leukemia - Product Status
  • Table 15: MCL1 Companion Diagnostic Assay - Leukemia - Product Description
  • Table 16: TP53/ATM Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Status
  • Table 17: TP53/ATM Companion Diagnostic Assay - Chronic Lymphocytic Leukemia - Product Description
  • Table 18: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Status
  • Table 20: Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Description
  • Table 21: Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: MRD Assay - B-cell Acute Lymphoblastic Leukemia - Product Status
  • Table 23: MRD Assay - B-cell Acute Lymphoblastic Leukemia - Product Description
  • Table 24: BioSense Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Diagnostic Assay - BCR-ABL (+) - Product Status
  • Table 26: Diagnostic Assay - BCR-ABL (+) - Product Description
  • Table 27: Cancer Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: LeukA - Leukemia - Product Status
  • Table 29: LeukA - Leukemia - Product Description
  • Table 30: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: XPERT CLL Monitoring Test - Product Status
  • Table 32: XPERT CLL Monitoring Test - Product Description
  • Table 33: Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: NanoMabKv - Leukemia - Product Status
  • Table 35: NanoMabKv - Leukemia - Product Description
  • Table 36: Diagnovus, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Diagnostic Assay - Leukemia - Product Status
  • Table 38: Diagnostic Assay - Leukemia - Product Description
  • Table 39: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: AML-ETO 1 Assay - Product Status
  • Table 41: AML-ETO 1 Assay - Product Description
  • Table 42: C-Kit 816 Assay - Product Status
  • Table 43: C-Kit 816 Assay - Product Description
  • Table 44: C-Kit 822 Assay - Product Status
  • Table 45: C-Kit 822 Assay - Product Description
  • Table 46: LIAISON IAM - Acute Lymphoblastic Leukemia Test - Product Status
  • Table 47: LIAISON IAM - Acute Lymphoblastic Leukemia Test - Product Description
  • Table 48: LIAISON IAM - Acute Promyelocitic Leukemia - Product Status
  • Table 49: LIAISON IAM - Acute Promyelocitic Leukemia - Product Description
  • Table 50: Eutropics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Companion Diagnostic Assay - Alvocidib - Product Status
  • Table 52: Companion Diagnostic Assay - Alvocidib - Product Description
  • Table 53: Diagnostic Test - Acute Lymphoid Leukemia - Product Status
  • Table 54: Diagnostic Test - Acute Lymphoid Leukemia - Product Description
  • Table 55: EU-4030 Companion Diagnostic Assay - AML - Product Status
  • Table 56: EU-4030 Companion Diagnostic Assay - AML - Product Description
  • Table 57: Gendiag Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Hemato inCode DNA Chip - Product Status
  • Table 59: Hemato inCode DNA Chip - Product Description
  • Table 60: Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Diagnostic Test - Pre-Leukemia - Product Status
  • Table 62: Diagnostic Test - Pre-Leukemia - Product Description
  • Table 63: InVivoScribe Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: FLT3 Biomarker - Acute Myeloid Leukemia - Product Status
  • Table 65: FLT3 Biomarker - Acute Myeloid Leukemia - Product Description
  • Table 66: IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Diagnostic Test - Leukemia - Product Status
  • Table 68: Diagnostic Test - Leukemia - Product Description
  • Table 69: Jaden BioScience Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Ultrasensitive Assay - B-Cell Chronic Lymphocytic Leukemia - Product Status
  • Table 71: Ultrasensitive Assay - B-Cell Chronic Lymphocytic Leukemia - Product Description
  • Table 72: MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Notch1 NGS Test - Chronic Lymphocytic Leukemia - Product Status
  • Table 74: Notch1 NGS Test - Chronic Lymphocytic Leukemia - Product Description
  • Table 75: Monoquant Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: PCR-Based Diagnostic Test - Chronic Myeloid Leukemia - Product Status
  • Table 77: PCR-Based Diagnostic Test - Chronic Myeloid Leukemia - Product Description
  • Table 78: Nodality, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Acute Myeloid Leukemia Induction Response Test - Product Status
  • Table 80: Acute Myeloid Leukemia Induction Response Test - Product Description
  • Table 81: NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: NUC-10000 Companion Diagnostic Test - Product Status
  • Table 83: NUC-10000 Companion Diagnostic Test - Product Description
  • Table 84: NUC-11000 Companion Diagnostic Test - Product Status
  • Table 85: NUC-11000 Companion Diagnostic Test - Product Description
  • Table 86: NUC-12000 Companion Diagnostic Test - Product Status
  • Table 87: NUC-12000 Companion Diagnostic Test - Product Description
  • Table 88: NUC-5435 Companion Diagnostic Test - Product Status
  • Table 89: NUC-5435 Companion Diagnostic Test - Product Description
  • Table 90: NUC-6285 Companion Diagnostic Test - Product Status
  • Table 91: NUC-6285 Companion Diagnostic Test - Product Description
  • Table 92: NUC-7000 Companion Diagnostic Test - Product Status
  • Table 93: NUC-7000 Companion Diagnostic Test - Product Description
  • Table 94: NUC-8000 Companion Diagnostic Test - Product Status
  • Table 95: NUC-8000 Companion Diagnostic Test - Product Description
  • Table 96: Nuclea Biotechnologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 97: CML Detection Test - Product Status
  • Table 98: CML Detection Test - Product Description
  • Table 99: MLL Detection Test - Product Status
  • Table 100: MLL Detection Test - Product Description
  • Table 101: OncoVista Innovative Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: OVI-123(Cordycepin) Biomarker - Leukemia - Product Status
  • Table 103: OVI-123(Cordycepin) Biomarker - Leukemia - Product Description
  • Table 104: Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: ABL Assay - Product Status
  • Table 106: ABL Assay - Product Description
  • Table 107: Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: Companion Diagnostic Test - Inotuzumab Ozogamicin - Product Status
  • Table 109: Companion Diagnostic Test - Inotuzumab Ozogamicin - Product Description
  • Table 110: Skyline Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 111: ALL Profiler - Product Status
  • Table 112: ALL Profiler - Product Description
  • Table 113: AMLProfiler - Product Status
  • Table 114: AMLProfiler - Product Description
  • Table 115: St. Jude Children's Research Hospital, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Biomarker Based Assay - MRD ALL - Product Status
  • Table 117: Biomarker Based Assay - MRD ALL - Product Description
  • Table 118: Diagnostic Assay - MRD In Leukemia - Product Status
  • Table 119: Diagnostic Assay - MRD In Leukemia - Product Description
  • Table 120: The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Prognostic Test - Chronic Lymphocytic Leukemia - Product Status
  • Table 122: Prognostic Test - Chronic Lymphocytic Leukemia - Product Description
  • Table 123: University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview
  • Table 124: Prognostic Assay - Chronic Lymphocytic Leukemia - Product Status
  • Table 125: Prognostic Assay - Chronic Lymphocytic Leukemia - Product Description
  • Table 126: University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • Table 127: Biomarker Assay - Chronic Lymphocytic Leukemia - Product Status
  • Table 128: Biomarker Assay - Chronic Lymphocytic Leukemia - Product Description
  • Table 129: ROR1 Monoclonal Antibody Assay - Product Status
  • Table 130: ROR1 Monoclonal Antibody Assay - Product Description
  • Table 131: University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
  • Table 132: Multiple Methylation Sensitive Enzyme Restriction PCR (MSR-PCR) Assay - Product Status
  • Table 133: Multiple Methylation Sensitive Enzyme Restriction PCR (MSR-PCR) Assay - Product Description
  • Table 134: Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 135: Sentosa SQ Leukemia Panel - Product Status
  • Table 136: Sentosa SQ Leukemia Panel - Product Description
  • Table 137: Vivia Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 138: Personalized Medicine Test - Acute Lymphocytic Leukemia - Product Status
  • Table 139: Personalized Medicine Test - Acute Lymphocytic Leukemia - Product Description
  • Table 140: Personalized Medicine Test - Chronic Lymphocytic Leukemia - Product Status
  • Table 141: Personalized Medicine Test - Chronic Lymphocytic Leukemia - Product Description
  • Table 142: Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 143: Diagnostic Assay - Acute Erythroid Leukemia - Product Status
  • Table 144: Diagnostic Assay - Acute Erythroid Leukemia - Product Description
  • Table 145: Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 146: Theranostic Test - Leukemia Fusion - Product Status
  • Table 147: Theranostic Test - Leukemia Fusion - Product Description
  • Table 148: Theranostic Test - Leukemia Mutation - Product Status
  • Table 149: Theranostic Test - Leukemia Mutation - Product Description
  • Table 150: Glossary

List of Figures

  • Figure 1: Leukemia - Pipeline Products by Stage of Development
  • Figure 2: Leukemia - Pipeline Products by Territory
  • Figure 3: Leukemia - Pipeline Products by Regulatory Path
  • Figure 4: Leukemia - Pipeline Products by Estimated Approval Date
Back to Top